215 related articles for article (PubMed ID: 38159229)
1. Human Papilloma Virus-Infected Cells.
Cruz-Gregorio A; Aranda-Rivera AK
Subcell Biochem; 2023; 106():213-226. PubMed ID: 38159229
[TBL] [Abstract][Full Text] [Related]
2. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
3. Phosphorylation of Human Papillomavirus Type 16 L2 Contributes to Efficient Virus Infectious Entry.
Broniarczyk J; Massimi P; Pim D; Bergant Marušič M; Myers MP; Garcea RL; Banks L
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996086
[TBL] [Abstract][Full Text] [Related]
4. Expression of different L1 isoforms of
Fu Y; Cao R; Schäfer M; Stephan S; Braspenning-Wesch I; Schmitt L; Bischoff R; Müller M; Schäfer K; Vinzón SE; Rösl F; Hasche D
Elife; 2020 Aug; 9():. PubMed ID: 32746966
[TBL] [Abstract][Full Text] [Related]
5. Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?
Yadav R; Zhai L; Tumban E
Viruses; 2019 Dec; 12(1):. PubMed ID: 31877975
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Dec; 31 Suppl 5():F1-31. PubMed ID: 24331745
[TBL] [Abstract][Full Text] [Related]
7. Maturation of the human papillomavirus 16 capsid.
Cardone G; Moyer AL; Cheng N; Thompson CD; Dvoretzky I; Lowy DR; Schiller JT; Steven AC; Buck CB; Trus BL
mBio; 2014 Aug; 5(4):e01104-14. PubMed ID: 25096873
[TBL] [Abstract][Full Text] [Related]
8. Papillomaviruses and cancer: commonalities and differences in HPV carcinogenesis at different sites of the body.
Egawa N
Int J Clin Oncol; 2023 Aug; 28(8):956-964. PubMed ID: 37199886
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
[TBL] [Abstract][Full Text] [Related]
10. Broad Cross-Protection Is Induced in Preclinical Models by a Human Papillomavirus Vaccine Composed of L1/L2 Chimeric Virus-Like Particles.
Boxus M; Fochesato M; Miseur A; Mertens E; Dendouga N; Brendle S; Balogh KK; Christensen ND; Giannini SL
J Virol; 2016 Jul; 90(14):6314-25. PubMed ID: 27147749
[TBL] [Abstract][Full Text] [Related]
11. Efficient Inhibition of Human Papillomavirus Infection by L2 Minor Capsid-Derived Lipopeptide.
Yan H; Foo SS; Chen W; Yoo JS; Shin WJ; Wu C; Jung JU
mBio; 2019 Aug; 10(4):. PubMed ID: 31387913
[TBL] [Abstract][Full Text] [Related]
12. Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16.
Chen J; Wang D; Wang Z; Wu K; Wei S; Chi X; Qian C; Xu Y; Zhou L; Li Y; Zhang S; Li T; Kong Z; Wang Y; Zheng Q; Yu H; Zhao Q; Zhang J; Xia N; Li S; Gu Y
J Virol; 2023 Mar; 97(3):e0181922. PubMed ID: 36815785
[TBL] [Abstract][Full Text] [Related]
13. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review.
Graham SV
Clin Sci (Lond); 2017 Sep; 131(17):2201-2221. PubMed ID: 28798073
[TBL] [Abstract][Full Text] [Related]
14. [HPV (Human Papilloma Virus) implication in other cancers than gynaecological].
Badoual C; Tartour E; Roussel H; Bats AS; Pavie J; Pernot S; Weiss L; Mohamed AS; Thariat J; Hoffmann C; Péré H
Rev Med Interne; 2015 Aug; 36(8):540-7. PubMed ID: 25661671
[TBL] [Abstract][Full Text] [Related]
15. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
16. Laboratory-developed L1 sequencing and type-specific, real-time polymerase chain reaction for the detection and typing of human papillomaviruses in formalin-fixed, paraffin-embedded tissues.
Mills A; Balasubramaniam R; Longacre TA; Kong CS; Pinsky BA
Arch Pathol Lab Med; 2013 Jan; 137(1):50-4. PubMed ID: 23276174
[TBL] [Abstract][Full Text] [Related]
17. Recent Developments in Human Papillomavirus (HPV) Vaccinology.
Williamson AL
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515128
[TBL] [Abstract][Full Text] [Related]
18. Etiological role of human papillomavirus infection for inverted papilloma of the bladder.
Shigehara K; Sasagawa T; Doorbar J; Kawaguchi S; Kobori Y; Nakashima T; Shimamura M; Maeda Y; Miyagi T; Kitagawa Y; Kadono Y; Konaka H; Mizokami A; Koh E; Namiki M
J Med Virol; 2011 Feb; 83(2):277-85. PubMed ID: 21181923
[TBL] [Abstract][Full Text] [Related]
19. Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types.
Kwak K; Jiang R; Wang JW; Jagu S; Kirnbauer R; Roden RB
PLoS One; 2014; 9(5):e97232. PubMed ID: 24816794
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of various human tissues to transformation in vivo with human papillomavirus type 11.
Kreider JW; Howett MK; Stoler MH; Zaino RJ; Welsh P
Int J Cancer; 1987 Apr; 39(4):459-65. PubMed ID: 3030939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
